LIVZON PHARMA (01513) spent 8.7832 million yuan on September 24 to repurchase 250,000 shares of A shares.
Lizhu Pharmaceutical (01513) announced that the company invested 8.7832 million yuan on September 24, 2024...
LIVZON PHARMA (01513) announced that the company spent 8.7832 million yuan to repurchase 250,000 A shares on September 24, 2024. The repurchase price was between 34.95 yuan and 35.76 yuan per share.
Related Articles
ANHUI EXPRESSWAY (00995) plans to increase its investment in the traffic control information industry by 95 million RMB, increasing its shareholding ratio to 36.76%.
Medprin Regenerative Medical Technologies (301033.SZ) Shareholders Shenzhen Kaiying and Fengyan Fund plan to reduce their holdings by no more than 1.22%.
On December 12th, the GREEN TEA GROUP (06831) spent 1.3973 million Hong Kong dollars to repurchase 22.96 thousand shares.
ANHUI EXPRESSWAY (00995) plans to increase its investment in the traffic control information industry by 95 million RMB, increasing its shareholding ratio to 36.76%.
Medprin Regenerative Medical Technologies (301033.SZ) Shareholders Shenzhen Kaiying and Fengyan Fund plan to reduce their holdings by no more than 1.22%.
On December 12th, the GREEN TEA GROUP (06831) spent 1.3973 million Hong Kong dollars to repurchase 22.96 thousand shares.
RECOMMEND
Valued At $10 Trillion, The Largest IPO In History Is Coming As SpaceX Announces Listing Plan
12/12/2025
Five Imperatives And Eight Tasks: Central Meeting Specifies Next Year’s Economic Work, Highlights Identified
12/12/2025
Over 100 New Listings In Hong Kong This Year As Total Fundraising Tops HKD 270 Billion, Eighteen “A+H” Dual Listings
12/12/2025
